Council of Europe’s Committee on Bioethics (DH-BIO) on genome editing technologies and the Oviedo Convention
“At its 18th plenary meeting (1-4 June 2021), the Committee on Bioethics of the Council of Europe adopted the following conclusions regarding genome editing technologies”:
In accordance with its Statement on genome editing technologies adopted in December 2015 and its Strategic Action Plan on Human Rights and Technologies in Biomedicine (2020-2025); the Committee on Bioethics (DH-BIO) examined Article 13 of the Oviedo Convention in the light of developments in human genome editing.
Taking into account the technical and scientific aspects of these developments as well as the ethical issues they raise, it considered that the conditions were not met for a modification of the provisions of Article 13.
However, it agreed on the need to provide clarifications, in particular on the terms “preventive, diagnostic and therapeutic” and to avoid misinterpretation of the applicability of this provision to “research”.
Read the full press release.
Download the abridged report of the 18th plenary meeting.
OpenEdition vous propose de citer ce billet de la manière suivante :
egennet (19 août 2021). Council of Europe’s Committee on Bioethics (DH-BIO) on genome editing technologies and the Oviedo Convention. ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/o5se